MedTrace Logo

Exercise and GLP-1 RA on Insulin Secretion

NCT04383197 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-02-11

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of endurance exercise on insulin secretory capacity, alone or in addition to treatment with the glucagon-like-peptide receptor agonist semaglutide, in patients with type 2 diabetes.

Conditions

Interventions

BEHAVIORAL

Endurance exercise training

Ergometer cycling at 70 % of VO2 max, 45 minutes, 3 times a week

DRUG

Semaglutide

3 months of therapeutic treatment with semaglutide

Sponsors & Collaborators

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Flemming Dela · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-10
Primary Completion
2021-08-31
Completion
2022-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04383197 on ClinicalTrials.gov